| No headlines available for SIE.AX. |
| |
| SciGen Limited (SIE) is a biopharmaceutical company
involved in co-developing and marketing genetically
engineered biopharmaceutical products for human healthcare.
SciGen focuses in the areas of gastroenterology,
endocrinology and immunology. Its product portfolio includes
a third generation Hepatitis B Vaccine and therapeutics such
as rhuman Growth Hormone, rhuman Insulin, GCSF and
Interferon Alpha 2b. | | |
|